Regenerative Medicine Market in Japan 2026-2030

1.1 Market overview

• Executive Summary - Chart on Market Overview
• Executive Summary - Data Table on Market Overview
• Executive Summary - Chart on Country Market Characteristics
• Executive Summary - Chart on Market Segmentation by Application
• Executive Summary - Chart on Market Segmentation by Technology
• Executive Summary - Chart on Market Segmentation by End-user
• Executive Summary - Chart on Company Market Positioning

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

• Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

• Overview on factors of disruption

2.4 Impact of drivers and challenges

• Impact of drivers and challenges in 2025 and 2030

3.1 Market ecosystem

• Chart on Parent Market
• Data Table on - Parent Market

3.2 Market characteristics

• Chart on Market characteristics analysis

3.3 Value chain analysis

• Chart on Value chain analysis

4.1 Market definition

• Data Table on Offerings of companies included in the market definition

4.2 Market segment analysis

• Market segments

4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030

• Chart on Japan - Market size and forecast 2025-2030 ($ million)
• Data Table on Japan - Market size and forecast 2025-2030 ($ million)
• Chart on Japan: Year-over-year growth 2025-2030 (%)
• Data Table on Japan: Year-over-year growth 2025-2030 (%)

5.1 Regenerative Medicine Market in Japan 2020 - 2024

• Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2020 - 2024 ($ million)

5.2 Application segment analysis 2020 - 2024

• Historic Market Size - Application Segment 2020 - 2024 ($ million)

5.3 Technology segment analysis 2020 - 2024

• Historic Market Size - Technology Segment 2020 - 2024 ($ million)

5.4 End-user segment analysis 2020 - 2024

• Historic Market Size - End-user Segment 2020 - 2024 ($ million)

6.1 The AI impact on Regenerative Medicine Market in Japan

7.1 Five forces summary

• Five forces analysis - Comparison between 2025 and 2030

7.2 Bargaining power of buyers

• Bargaining power of buyers - Impact of key factors 2025 and 2030

7.3 Bargaining power of suppliers

• Bargaining power of suppliers - Impact of key factors in 2025 and 2030

7.4 Threat of new entrants

• Threat of new entrants - Impact of key factors in 2025 and 2030

7.5 Threat of substitutes

• Threat of substitutes - Impact of key factors in 2025 and 2030

7.6 Threat of rivalry

• Threat of rivalry - Impact of key factors in 2025 and 2030

7.7 Market condition

• Chart on Market condition - Five forces 2025 and 2030

8.1 Market segments

• Chart on Application - Market share 2025-2030 (%)
• Data Table on Application - Market share 2025-2030 (%)

8.2 Comparison by Application

• Chart on Comparison by Application
• Data Table on Comparison by Application

8.3 Oncology - Market size and forecast 2025-2030

• Chart on Oncology - Market size and forecast 2025-2030 ($ million)
• Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
• Chart on Oncology - Year-over-year growth 2025-2030 (%)
• Data Table on Oncology - Year-over-year growth 2025-2030 (%)

8.4 Musculoskeletal - Market size and forecast 2025-2030

• Chart on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
• Data Table on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
• Chart on Musculoskeletal - Year-over-year growth 2025-2030 (%)
• Data Table on Musculoskeletal - Year-over-year growth 2025-2030 (%)

8.5 Dermatology - Market size and forecast 2025-2030

• Chart on Dermatology - Market size and forecast 2025-2030 ($ million)
• Data Table on Dermatology - Market size and forecast 2025-2030 ($ million)
• Chart on Dermatology - Year-over-year growth 2025-2030 (%)
• Data Table on Dermatology - Year-over-year growth 2025-2030 (%)

8.6 Others - Market size and forecast 2025-2030

• Chart on Others - Market size and forecast 2025-2030 ($ million)
• Data Table on Others - Market size and forecast 2025-2030 ($ million)
• Chart on Others - Year-over-year growth 2025-2030 (%)
• Data Table on Others - Year-over-year growth 2025-2030 (%)

8.7 Market opportunity by Application

• Market opportunity by Application ($ million)
• Data Table on Market opportunity by Application ($ million)

9.1 Market segments

• Chart on Technology - Market share 2025-2030 (%)
• Data Table on Technology - Market share 2025-2030 (%)

9.2 Comparison by Technology

• Chart on Comparison by Technology
• Data Table on Comparison by Technology

9.3 Cell and tissue-based - Market size and forecast 2025-2030

• Chart on Cell and tissue-based - Market size and forecast 2025-2030 ($ million)
• Data Table on Cell and tissue-based - Market size and forecast 2025-2030 ($ million)
• Chart on Cell and tissue-based - Year-over-year growth 2025-2030 (%)
• Data Table on Cell and tissue-based - Year-over-year growth 2025-2030 (%)

9.4 Gene therapy - Market size and forecast 2025-2030

• Chart on Gene therapy - Market size and forecast 2025-2030 ($ million)
• Data Table on Gene therapy - Market size and forecast 2025-2030 ($ million)
• Chart on Gene therapy - Year-over-year growth 2025-2030 (%)
• Data Table on Gene therapy - Year-over-year growth 2025-2030 (%)

9.5 Market opportunity by Technology

• Market opportunity by Technology ($ million)
• Data Table on Market opportunity by Technology ($ million)

10.1 Market segments

• Chart on End-user - Market share 2025-2030 (%)
• Data Table on End-user - Market share 2025-2030 (%)

10.2 Comparison by End-user

• Chart on Comparison by End-user
• Data Table on Comparison by End-user

10.3 Hospitals and clinics - Market size and forecast 2025-2030

• Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
• Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
• Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
• Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)

10.4 Speciality centers - Market size and forecast 2025-2030

• Chart on Speciality centers - Market size and forecast 2025-2030 ($ million)
• Data Table on Speciality centers - Market size and forecast 2025-2030 ($ million)
• Chart on Speciality centers - Year-over-year growth 2025-2030 (%)
• Data Table on Speciality centers - Year-over-year growth 2025-2030 (%)

10.5 Government and research institutes - Market size and forecast 2025-2030

• Chart on Government and research institutes - Market size and forecast 2025-2030 ($ million)
• Data Table on Government and research institutes - Market size and forecast 2025-2030 ($ million)
• Chart on Government and research institutes - Year-over-year growth 2025-2030 (%)
• Data Table on Government and research institutes - Year-over-year growth 2025-2030 (%)

10.6 Market opportunity by End-user

• Market opportunity by End-user ($ million)
• Data Table on Market opportunity by End-user ($ million)

11.1 Customer landscape overview

• Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12.1 Market drivers

• Pioneering regulatory environment accelerating commercialization
• Comprehensive governmental support and strategic national investment
• Compelling market demand stemming from demographic imperatives

12.2 Market challenges

• Navigating complex reimbursement frameworks and pricing pressures
• Overcoming manufacturing scalability hurdles and high cost of goods
• Addressing uncertainty from long-term safety and efficacy data gaps

12.3 Impact of drivers and challenges

• Impact of drivers and challenges in 2025 and 2030

12.4 Market opportunities

• Strategic pivot towards allogeneic and off-the-shelf therapies
• Integration of automation and advanced bioprocessing to industrialize manufacturing
• Proliferation of strategic alliances and ecosystem-based development models

13.1 Overview
13.2 Competitive Landscape

• Overview on criticality of inputs and factors of differentiation

13.3 Landscape disruption

• Overview on factors of disruption

13.4 Industry risks

• Impact of key risks on business

14.1 Companies profiled

• Companies covered

14.2 Company ranking index

• Company ranking index

14.3 Market positioning of companies

• Matrix on companies position and classification

14.4 Astellas Pharma Inc.

• Astellas Pharma Inc. - Overview
• Astellas Pharma Inc. - Product / Service
• Astellas Pharma Inc. - Key offerings
• SWOT

14.5 Bristol Myers Squibb Co.

• Bristol Myers Squibb Co. - Overview
• Bristol Myers Squibb Co. - Product / Service
• Bristol Myers Squibb Co. - Key news
• Bristol Myers Squibb Co. - Key offerings
• SWOT

14.6 Cyfuse Biomedical K.K.

• Cyfuse Biomedical K.K. - Overview
• Cyfuse Biomedical K.K. - Product / Service
• Cyfuse Biomedical K.K. - Key offerings
• SWOT

14.7 Daiichi Sankyo Co. Ltd.

• Daiichi Sankyo Co. Ltd. - Overview
• Daiichi Sankyo Co. Ltd. - Business segments
• Daiichi Sankyo Co. Ltd. - Key offerings
• Daiichi Sankyo Co. Ltd. - Segment focus
• SWOT

14.8 FUJIFILM Holdings Corp.

• FUJIFILM Holdings Corp. - Overview
• FUJIFILM Holdings Corp. - Business segments
• FUJIFILM Holdings Corp. - Key news
• FUJIFILM Holdings Corp. - Key offerings
• FUJIFILM Holdings Corp. - Segment focus
• SWOT

14.9 Gilead Sciences Inc.

• Gilead Sciences Inc. - Overview
• Gilead Sciences Inc. - Product / Service
• Gilead Sciences Inc. - Key news
• Gilead Sciences Inc. - Key offerings
• SWOT

14.10 JCR Pharmaceticals Co. Ltd.

• JCR Pharmaceticals Co. Ltd. - Overview
• JCR Pharmaceticals Co. Ltd. - Product / Service
• JCR Pharmaceticals Co. Ltd. - Key offerings
• SWOT

14.11 Kyowa Kirin Co. Ltd.

• Kyowa Kirin Co. Ltd. - Overview
• Kyowa Kirin Co. Ltd. - Business segments
• Kyowa Kirin Co. Ltd. - Key offerings
• Kyowa Kirin Co. Ltd. - Segment focus
• SWOT

14.12 Megakaryon Corp.

• Megakaryon Corp. - Overview
• Megakaryon Corp. - Product / Service
• Megakaryon Corp. - Key offerings
• SWOT

14.13 Metcela Inc.

• Metcela Inc. - Overview
• Metcela Inc. - Product / Service
• Metcela Inc. - Key offerings
• SWOT

14.14 Novartis AG

• Novartis AG - Overview
• Novartis AG - Business segments
• Novartis AG - Key news
• Novartis AG - Key offerings
• Novartis AG - Segment focus
• SWOT

14.15 ROHTO Pharmaceutical Co. Ltd.

• ROHTO Pharmaceutical Co. Ltd. - Overview
• ROHTO Pharmaceutical Co. Ltd. - Business segments
• ROHTO Pharmaceutical Co. Ltd. - Key offerings
• ROHTO Pharmaceutical Co. Ltd. - Segment focus
• SWOT

14.16 Takara Bio Inc.

• Takara Bio Inc. - Overview
• Takara Bio Inc. - Product / Service
• Takara Bio Inc. - Key offerings
• SWOT

14.17 Takeda Pharmaceutical Ltd.

• Takeda Pharmaceutical Ltd. - Overview
• Takeda Pharmaceutical Ltd. - Product / Service
• Takeda Pharmaceutical Ltd. - Key news
• Takeda Pharmaceutical Ltd. - Key offerings
• SWOT

14.18 Terumo Corp.

• Terumo Corp. - Overview
• Terumo Corp. - Business segments
• Terumo Corp. - Key news
• Terumo Corp. - Key offerings
• Terumo Corp. - Segment focus
• SWOT

15.1 Scope of the report

• Market definition
• Objectives
• Notes and caveats

15.2 Inclusions and exclusions checklist

• Inclusions checklist
• Exclusions checklist

15.3 Currency conversion rates for US$

• Currency conversion rates for US$

15.4 Research methodology

• Research methodology

15.5 Data procurement

• Information sources

15.6 Data validation

• Data validation

15.7 Validation techniques employed for market sizing

• Validation techniques employed for market sizing

15.8 Data synthesis

• Data synthesis

15.9 360 degree market analysis

• 360 degree market analysis

15.10 List of abbreviations

• List of abbreviations

Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Country Market Characteristics
Exhibit 4: Executive Summary - Chart on Market Segmentation by Application
Exhibit 5: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Company Market Positioning
Exhibit 8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 9: Overview on criticality of inputs and factors of differentiation
Exhibit 10: Overview on factors of disruption
Exhibit 11: Impact of drivers and challenges in 2025 and 2030
Exhibit 12: Chart on Parent Market
Exhibit 13: Data Table on - Parent Market
Exhibit 14: Chart on Market characteristics analysis
Exhibit 15: Chart on Value chain analysis
Exhibit 16: Data Table on Offerings of companies included in the market definition
Exhibit 17: Market segments
Exhibit 18: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 19: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 20: Chart on Japan: Year-over-year growth 2025-2030 (%)
Exhibit 21: Data Table on Japan: Year-over-year growth 2025-2030 (%)
Exhibit 22: Historic Market Size - Data Table on Regenerative Medicine Market in Japan 2020 - 2024 ($ million)
Exhibit 23: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 24: Historic Market Size - Technology Segment 2020 - 2024 ($ million)
Exhibit 25: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 26: Five forces analysis - Comparison between 2025 and 2030
Exhibit 27: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 28: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 29: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 30: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 31: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 32: Chart on Market condition - Five forces 2025 and 2030
Exhibit 33: Chart on Application - Market share 2025-2030 (%)
Exhibit 34: Data Table on Application - Market share 2025-2030 (%)
Exhibit 35: Chart on Comparison by Application
Exhibit 36: Data Table on Comparison by Application
Exhibit 37: Chart on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 38: Data Table on Oncology - Market size and forecast 2025-2030 ($ million)
Exhibit 39: Chart on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 40: Data Table on Oncology - Year-over-year growth 2025-2030 (%)
Exhibit 41: Chart on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 42: Data Table on Musculoskeletal - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Chart on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 44: Data Table on Musculoskeletal - Year-over-year growth 2025-2030 (%)
Exhibit 45: Chart on Dermatology - Market size and forecast 2025-2030 ($ million)
Exhibit 46: Data Table on Dermatology - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Chart on Dermatology - Year-over-year growth 2025-2030 (%)
Exhibit 48: Data Table on Dermatology - Year-over-year growth 2025-2030 (%)
Exhibit 49: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 50: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 52: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 53: Market opportunity by Application ($ million)
Exhibit 54: Data Table on Market opportunity by Application ($ million)
Exhibit 55: Chart on Technology - Market share 2025-2030 (%)
Exhibit 56: Data Table on Technology - Market share 2025-2030 (%)
Exhibit 57: Chart on Comparison by Technology
Exhibit 58: Data Table on Comparison by Technology
Exhibit 59: Chart on Cell and tissue-based - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Data Table on Cell and tissue-based - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Chart on Cell and tissue-based - Year-over-year growth 2025-2030 (%)
Exhibit 62: Data Table on Cell and tissue-based - Year-over-year growth 2025-2030 (%)
Exhibit 63: Chart on Gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 64: Data Table on Gene therapy - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Chart on Gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 66: Data Table on Gene therapy - Year-over-year growth 2025-2030 (%)
Exhibit 67: Market opportunity by Technology ($ million)
Exhibit 68: Data Table on Market opportunity by Technology ($ million)
Exhibit 69: Chart on End-user - Market share 2025-2030 (%)
Exhibit 70: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 71: Chart on Comparison by End-user
Exhibit 72: Data Table on Comparison by End-user
Exhibit 73: Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 75: Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 76: Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Exhibit 77: Chart on Speciality centers - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Data Table on Speciality centers - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Chart on Speciality centers - Year-over-year growth 2025-2030 (%)
Exhibit 80: Data Table on Speciality centers - Year-over-year growth 2025-2030 (%)
Exhibit 81: Chart on Government and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Data Table on Government and research institutes - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Chart on Government and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 84: Data Table on Government and research institutes - Year-over-year growth 2025-2030 (%)
Exhibit 85: Market opportunity by End-user ($ million)
Exhibit 86: Data Table on Market opportunity by End-user ($ million)
Exhibit 87: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 88: Impact of drivers and challenges in 2025 and 2030
Exhibit 89: Overview on criticality of inputs and factors of differentiation
Exhibit 90: Overview on factors of disruption
Exhibit 91: Impact of key risks on business
Exhibit 92: Companies covered
Exhibit 93: Company ranking index
Exhibit 94: Matrix on companies position and classification
Exhibit 95: Astellas Pharma Inc. - Overview
Exhibit 96: Astellas Pharma Inc. - Product / Service
Exhibit 97: Astellas Pharma Inc. - Key offerings
Exhibit 98: SWOT
Exhibit 99: Bristol Myers Squibb Co. - Overview
Exhibit 100: Bristol Myers Squibb Co. - Product / Service
Exhibit 101: Bristol Myers Squibb Co. - Key news
Exhibit 102: Bristol Myers Squibb Co. - Key offerings
Exhibit 103: SWOT
Exhibit 104: Cyfuse Biomedical K.K. - Overview
Exhibit 105: Cyfuse Biomedical K.K. - Product / Service
Exhibit 106: Cyfuse Biomedical K.K. - Key offerings
Exhibit 107: SWOT
Exhibit 108: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 109: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 110: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 111: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibit 112: SWOT
Exhibit 113: FUJIFILM Holdings Corp. - Overview
Exhibit 114: FUJIFILM Holdings Corp. - Business segments
Exhibit 115: FUJIFILM Holdings Corp. - Key news
Exhibit 116: FUJIFILM Holdings Corp. - Key offerings
Exhibit 117: FUJIFILM Holdings Corp. - Segment focus
Exhibit 118: SWOT
Exhibit 119: Gilead Sciences Inc. - Overview
Exhibit 120: Gilead Sciences Inc. - Product / Service
Exhibit 121: Gilead Sciences Inc. - Key news
Exhibit 122: Gilead Sciences Inc. - Key offerings
Exhibit 123: SWOT
Exhibit 124: JCR Pharmaceticals Co. Ltd. - Overview
Exhibit 125: JCR Pharmaceticals Co. Ltd. - Product / Service
Exhibit 126: JCR Pharmaceticals Co. Ltd. - Key offerings
Exhibit 127: SWOT
Exhibit 128: Kyowa Kirin Co. Ltd. - Overview
Exhibit 129: Kyowa Kirin Co. Ltd. - Business segments
Exhibit 130: Kyowa Kirin Co. Ltd. - Key offerings
Exhibit 131: Kyowa Kirin Co. Ltd. - Segment focus
Exhibit 132: SWOT
Exhibit 133: Megakaryon Corp. - Overview
Exhibit 134: Megakaryon Corp. - Product / Service
Exhibit 135: Megakaryon Corp. - Key offerings
Exhibit 136: SWOT
Exhibit 137: Metcela Inc. - Overview
Exhibit 138: Metcela Inc. - Product / Service
Exhibit 139: Metcela Inc. - Key offerings
Exhibit 140: SWOT
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key news
Exhibit 144: Novartis AG - Key offerings
Exhibit 145: Novartis AG - Segment focus
Exhibit 146: SWOT
Exhibit 147: ROHTO Pharmaceutical Co. Ltd. - Overview
Exhibit 148: ROHTO Pharmaceutical Co. Ltd. - Business segments
Exhibit 149: ROHTO Pharmaceutical Co. Ltd. - Key offerings
Exhibit 150: ROHTO Pharmaceutical Co. Ltd. - Segment focus
Exhibit 151: SWOT
Exhibit 152: Takara Bio Inc. - Overview
Exhibit 153: Takara Bio Inc. - Product / Service
Exhibit 154: Takara Bio Inc. - Key offerings
Exhibit 155: SWOT
Exhibit 156: Takeda Pharmaceutical Ltd. - Overview
Exhibit 157: Takeda Pharmaceutical Ltd. - Product / Service
Exhibit 158: Takeda Pharmaceutical Ltd. - Key news
Exhibit 159: Takeda Pharmaceutical Ltd. - Key offerings
Exhibit 160: SWOT
Exhibit 161: Terumo Corp. - Overview
Exhibit 162: Terumo Corp. - Business segments
Exhibit 163: Terumo Corp. - Key news
Exhibit 164: Terumo Corp. - Key offerings
Exhibit 165: Terumo Corp. - Segment focus
Exhibit 166: SWOT
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
Exhibit 169: Currency conversion rates for US$
Exhibit 170: Research methodology
Exhibit 171: Information sources
Exhibit 172: Data validation
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Data synthesis
Exhibit 175: 360 degree market analysis
Exhibit 176: List of abbreviations